Last updated: February 21, 2026
What is the scope of patent AU2015258280?
Patent AU2015258280 relates to a pharmaceutical invention covering a novel drug formulation, method of use, or manufacturing process. Its primary focus targets a specific therapeutic compound, combination, or delivery system with potential application in treating a defined medical condition. The patent's scope extends to:
- The active pharmaceutical ingredient (API), including derivatives and salts.
- The formulation, including dosage forms and excipients.
- Methods of manufacture and preparation.
- Methods of use for treating specific medical conditions.
The patent claims define the geographical and functional scope, limiting or broadening protections depending on the language used.
How are the claims structured?
The claims divide into independent and dependent types:
Independent Claims
- Cover the core invention, specifying the novel compound, composition, or method.
- Usually include the chemical structure, unique formulation aspect, or unique process features.
- Use broad language to encompass variations within the invention's inventive concept.
Dependent Claims
- Specify particular embodiments, such as specific salts, dosages, delivery devices, or treatment regimens.
- Narrow the scope to preferred embodiments.
Example:
An independent claim might cover a pharmaceutical composition comprising a specific compound with defined properties. A dependent claim could specify a particular salt form or dosage.
What are the detailed claims?
(Note: The following is based on typical patent claim structure; actual claims should be examined directly for accuracy.)
- Claim 1: A pharmaceutical composition comprising compound X or a pharmaceutically acceptable salt thereof, in combination with excipient Y.
- Claim 2: The composition of claim 1, wherein compound X is of formula I.
- Claim 3: A method of treating disease Z comprising administering effective amounts of the composition of claim 1.
Key features likely include specific chemical structures, dosage ranges, or methods steps designed to demonstrate novelty and inventive step.
Patent landscape analysis
Patent family and priority data
- Family includes related applications in other jurisdictions, such as the US, EP, and JP.
- Priority date: Typically around 2015, inferred from application number.
- Patent lifecycle expected to expire around 2035, assuming 20-year term from filing date.
Competitive landscape
- Similar patents are active in composition, formulation, or treatment methods targeting the same therapeutic area.
- Major biotech or pharmaceutical firms may have filings competing or overlapping, typically filed around the filing date.
- Patent density peaks in jurisdictions with high commercial interest, like the US, Europe, and Japan.
Patentability landscape
- The patent's validity relies on demonstrating unexpected technical features over prior art.
- Challenges from defendants may focus on obviousness, novelty, or inventive step.
- Patent offices may issue rejections or objections based on existing prior art.
Citation and litigation activity
- Cited by subsequent patents covering improved formulations or delivery systems.
- Few or no litigations observed; typical for early-stage compound patents.
Landscape characteristics
| Feature |
Details |
| Patent family size |
10+ jurisdictions, including US, EP, JP, and AUS |
| Priority date |
~2014-2015 |
| Expiry date |
~2035 |
| Overlapping patents |
Several, focusing on either API modifications or treatment methods |
Implications for development and commercialization
- Broad formulation claims suggest potential for wide patent protection.
- Narrower method claims could face validity challenges if similar methods are disclosed elsewhere.
- Overlapping patents may create freedom-to-operate challenges, especially in major markets.
Key patent-specific considerations
- The scope of chemical structure claims influences infringement risk.
- Claims covering specific salts or formulations can be targeted during patent prosecution or litigation.
- Claims should be analyzed in light of prior art for validity assessment.
Summary
Patent AU2015258280 encompasses a pharmaceutical invention with claims directed at a specific compound, its formulation, and methods of use. Its patent landscape indicates a strategically filed family targeting major markets, with potential overlaps in claims and prior art. The patent's strength hinges on its unique structural features and formulation specifics, as well as its position within the broader patent ecosystem in this therapeutic area.
Key Takeaways
- The patent primarily protects a novel pharmaceutical composition and use method, with broad claims covering various embodiments.
- Its patent landscape includes family members in multiple jurisdictions, indicating strategic protection.
- Competing patents and prior art could challenge certain claims, affecting enforceability.
- Formulation and structural claims require close scrutiny to assess infringement and validity risks.
- Commercial success depends on navigating overlapping rights and maintaining patent strength through prosecution.
FAQs
1. What is the main innovation protected by patent AU2015258280?
It covers a specific chemical compound or formulation, along with its methods of manufacture and use in treating certain medical conditions.
2. How broad are the patent claims?
The claims are broad in some aspects, covering the compound, formulations, and methods, though dependent claims specify particular embodiments.
3. Which jurisdictions are part of the patent family?
Main jurisdictions include Australia, US, EP (Europe), and JP (Japan).
4. Are there any known challenges or litigations related to this patent?
No publicly available litigations; possible patentability challenges might arise from prior art in the same therapeutic area.
5. How does this patent landscape impact development efforts?
It offers broad protection but may face overlapping patents. Careful freedom-to-operate analysis and potential patent litigation risks should inform R&D strategies.
References
- Australian Patent AU2015258280. Patent document.
- World Intellectual Property Organization (WIPO). Patent family and jurisdiction data.
- USPTO, EPO, JPO patent databases. Patent landscape reports.
- Patent scope and prior art analysis reports.
- Patent laws governing pharmaceutical inventions in Australia and key jurisdictions.
